The Charcot-Marie-Tooth Functional Outcome Measure (CMT-FOM)
Neurology2018Vol. 91(15), pp. e1381–e1384
Citations Over TimeTop 21% of 2018 papers
Katy Eichinger, Joshua Burns, Kayla Cornett, Chelsea Bacon, Mary Lohse Shepherd, Joan Mountain, Janet E. Sowden, Rosemary Shy, Michael E. Shy, David N. Herrmann
Abstract
The CMT-FOM is well tolerated and showed no floor/ceiling effects in an adult CMT1A cohort matching those likely to enter upcoming clinical trials. It appears to be reliable, and our data support convergent and known-groups validity in adults with CMT1A. Longitudinal studies further examining the psychometric properties of the CMT-FOM and its responsiveness to change before its application in therapeutic trials are necessary.
Related Papers
- → Detecting Trends Using Spearman's Rank Correlation Coefficient(2001)132 cited
- → Who discovered Spearman's rank correlation?(1995)52 cited
- → Total Diet Comparison in Fishes by Spearman Rank Correlation Coefficients(1974)104 cited
- → Detecting Trends Using Spearman's Rank Correlation Coefficient(2001)8 cited
- Spearman Rank Correlation Method Based on Trend Rank(2010)